Novartis AG vs Opendoor Technologies Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Opendoor Technologies Inc trades at $4.48 (market cap $4.29B). The key difference: Novartis AG is far larger — about 67.7× Opendoor Technologies Inc's market cap, and Novartis AG pays a 3.17% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| NVS | OPEN | |
|---|---|---|
Market Cap | $290.25B | $4.29B |
Sector | Health | Real Estate |
52-Week High | $168.62 | $10.52 |
52-Week Low | $113.50 | $1.84 |
Enterprise Value | $330.27B | $4.63B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →